$FORM

FORMFACTOR INC

8
0
1
—
$3.2M
SLESSOR MIKE
100%
See all $FORM insider activity →
Low

SLESSOR MIKE sold $1.4M of FORM

SLESSOR MIKE (CEO) sold 11,098 shares of FORMFACTOR INC (FORM) at an average of $125.20 ($124.23–$125.92, $1.39M total) across 3 trades on 2026-10-14 under a Rule 10b5-1 trading plan.

Stifel reiterates FormFactor stock rating after Teradyne deal

Stifel kept a Hold rating and $115 price target on FormFactor (FORM) after Teradyne (TER) agreed to a $300M equity stake, pending approval. FORM shares are down 7.8% this week but up 223% year-over-year. Q2 earnings beat estimates with $0.82 EPS and $258.2M revenue. Deutsche Bank initiated coverage with a Buy rating and $200 target, citing Nvidia and TSMC opportunities.

FORMFACTOR INC (FORM): Unregistered Sales of Equity Securities

FORMFACTOR INC (FORM) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. FormFactor and Teradyne Announce Strategic Collaboration to Accelerate Next-Generation Semiconductor Testing Companies to combine leadership in probe, interface, and test technologies to accelerate AI and high-performance compute deployments LIVERMORE, Calif. - October 12, 2026 —

FORM sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 9 news stories mentioning FORM (FORMFACTOR INC). Coverage has skewed bullish: 8 bullish, 0 neutral, and 1 bearish.

Recent FORM coverage spans market movers, financial news and insider activity.

In the last 30 days, FORM insiders filed 6 SEC Form 4 transactions — no purchases and 6 sales ($3.2M). The most active reporter was SLESSOR MIKE, CEO, with 6 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving FORM

AlphAI scores every news story that mentions FORM with an AI model for sentiment and relevance, and aggregates insider trades from FORMFACTOR INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $FORM

Score
$FORMMed

Stifel reiterates FormFactor stock rating after Teradyne deal

Stifel kept a Hold rating and $115 price target on FormFactor (FORM) after Teradyne (TER) agreed to a $300M equity stake, pending approval. FORM shares are down 7.8% this week but up 223% year-over-year. Q2 earnings beat estimates with $0.82 EPS and $258.2M revenue. Deutsche Bank initiated coverage with a Buy rating and $200 target, citing Nvidia and TSMC opportunities.

$FORMHigh

FORMFACTOR INC (FORM): Unregistered Sales of Equity Securities

FORMFACTOR INC (FORM) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. FormFactor and Teradyne Announce Strategic Collaboration to Accelerate Next-Generation Semiconductor Testing Companies to combine leadership in probe, interface, and test technologies to accelerate AI and high-performance compute deployments LIVERMORE, Calif. - October 12, 2026 —

$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$FORMHighAI 8/10

Why is FormFactor stock surging today?

FormFactor (FORM) stock rose 8.5% after Deutsche Bank initiated coverage with a Buy rating and $200 price target, citing opportunities in Nvidia's GPU supply chain and high bandwidth memory testing. The bank expects revenues from Nvidia to start in late 2026, with potential $0.2B sales by 2028. The broader market also supported gains, with the Nasdaq and S&P 500 advancing.

Related tickers